Tissue immunoreactive prolactin hormone in breast cancer

A. Castro, P. Buschbaum, M. Nadji, W. Voigt, J. Ziegels-Weissman, A. Morales

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

The prolactin contents of the cytosol extracts of 159 human mammary carcinomas was measured by specific radioimmunoassay. Of these extracts 157 contained measurable prolactin (detection limit, 7.8 ng/g tumor). The levels measured were in most cases greater than would be expected to be due to only serum contamination. The levels of prolactin did not correlate with either estrogen or progesterone receptor content of the tumors, or menopausal status of the patient.

Original languageEnglish (US)
Pages (from-to)159-170
Number of pages12
JournalResearch Communications in Chemical Pathology and Pharmacology
Volume29
Issue number1
StatePublished - Sep 12 1980

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Toxicology
  • Pharmacology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Tissue immunoreactive prolactin hormone in breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Castro, A., Buschbaum, P., Nadji, M., Voigt, W., Ziegels-Weissman, J., & Morales, A. (1980). Tissue immunoreactive prolactin hormone in breast cancer. Research Communications in Chemical Pathology and Pharmacology, 29(1), 159-170.